Nasdaq
NBP
NovaBridge Biosciences
- Health Care
- China
- Listed 2020
- 1 day
- +3.7%
- 1 month
- −15.8%
- 1 year
- −54.5%
$1.70 · Mkt cap $196M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
NovaBridge Biosciences
$1.70 · Mkt cap $196M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
NovaBridge Biosciences trades under the ticker NBP on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $196M. The last closing price was $1.70, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −54.5%, and −15.8% over the past month. Returns are price returns and exclude dividends.
This page exists because NBP is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.